Associations between polymorphisms in sex steroid related genes and autistic-like traits

Psychoneuroendocrinology

Volumn 38, Issue 11, 2013, Pages 2575-2584

  Zettergren, Anna ^a   Jonsson, Lina ^a   Johansson, Daniel ^a   Melke, Jonas ^a   Lundström, Sebastian ^a   Anckarsäter, Henrik ^a   Lichtenstein, Paul ^b   Westberg, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 alpha reductase; Association; Autism spectrum disorders; Autistic like traits; Estrogen receptor; Gene; Sex steroids; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; AROMATASE; CYTOCHROME P450 17; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SEX HORMONE BINDING GLOBULIN; STEROID 5ALPHA REDUCTASE 1; STEROID 5ALPHA REDUCTASE 2;

3' UNTRANSLATED REGION; ANDROGEN RECEPTOR GENE; ARTICLE; AUTISM; CYP17 GENE; CYP19 GENE; ENZYME ACTIVITY; ESTROGEN RECEPTOR 1 GENE; ESTROGEN RECEPTOR 2 GENE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SEX HORMONE BINDING GLOBULIN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID 5ALPHA REDUCTASE 1 GENE; STEROID 5ALPHA REDUCTASE 2 GENE;

5-ALPHA-REDUCTASE; ASSOCIATION; AUTISM SPECTRUM DISORDERS; AUTISTIC-LIKE TRAITS; ESTROGEN RECEPTOR; GENE; SEX STEROIDS; TESTOSTERONE;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GONADAL STEROID HORMONES; HUMANS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 84886095113     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.06.004     Document Type: Article

References (89)

1. Ahn J., Schumacher F.R., Berndt S.I., Pfeiffer R., Albanes D., Andriole G.L., Ardanaz E., Boeing H., Bueno-de-Mesquita B., Chanock S.J., Clavel-Chapelon F., Diver W.R., Feigelson H.S., Gaziano J.M., Giovannucci E., Haiman C.A., Henderson B.E., Hoover R.N., Kolonel L.N., Kraft P., et al. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum. Mol. Genet. 2009, 18(19):3749-3757.
2. Alonso P., Gratacos M., Segalas C., Escaramis G., Real E., Bayes M., Labad J., Pertusa A., Vallejo J., Estivill X., Menchon J.M. Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder. Psychoneuroendocrinology 2011, 36(4):473-483.
3. Anckarsater H., Lundstrom S., Kollberg L., Kerekes N., Palm C., Carlstrom E., Langstrom N., Magnusson P.K., Halldner L., Bolte S., Gillberg C., Gumpert C., Rastam M., Lichtenstein P. The child and adolescent twin study in Sweden (CATSS). Twin Res. Hum. Genet. 2011, 14(6):495-508.
4. Anney R., Klei L., Pinto D., Almeida J., Bacchelli E., Baird G., Bolshakova N., Bolte S., Bolton P.F., Bourgeron T., Brennan S., Brian J., Casey J., Conroy J., Correia C., Corsello C., Crawford E.L., de Jonge M., Delorme R., Duketis E., et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 2012, 21(21):4781-4792.
5. Baron-Cohen S., Lombardo M.V., Auyeung B., Ashwin E., Chakrabarti B., Knickmeyer R. Why are autism spectrum conditions more prevalent in males?. PLoS Biol. 2011, 9(6):e1001081.
6. Bejerot S., Eriksson J.M., Bonde S., Carlstrom K., Humble M.B., Eriksson E. The extreme male brain revisited: gender coherence in adults with autism spectrum disorder. Br. J. Psychiatry 2012, 201:116-123.
7. Castelli M.P., Casti A., Casu A., Frau R., Bortolato M., Spiga S., Ennas M.G. Regional distribution of 5alpha-reductase type 2 in the adult rat brain: an immunohistochemical analysis. Psychoneuroendocrinology 2013, 38(2):281-293.
8. Celec P., Tretinarova D., Minarik G., Ficek A., Szemes T., Lakatosova S., Schmidtova E., Turna J., Kadasi L., Ostatnikova D. Genetic polymorphisms related to testosterone metabolism in intellectually gifted boys. PLoS ONE 2013, 8(1):e54751.
9. Chakrabarti B., Dudbridge F., Kent L., Wheelwright S., Hill-Cawthorne G., Allison C., Banerjee-Basu S., Baron-Cohen S. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res. 2009, 2(3):157-177.
10. Constantino J.N., Todd R.D. Autistic traits in the general population: a twin study. Arch. Gen. Psychiatry 2003, 60(5):524-530.
11. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res. 2011, 1380:138-145.
12. De Bruin E.I., De Nijs P.F., Verheij F., Verhagen D.H., Ferdinand R.F. Autistic features in girls from a psychiatric sample are strongly associated with a low 2D:4D ratio. Autism 2009, 13(5):511-521.
13. Devlin B., Scherer S.W. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 2012, 22(3):229-237.
14. Ding E.L., Song Y., Manson J.E., Hunter D.J., Lee C.C., Rifai N., Buring J.E., Gaziano J.M., Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 2009, 361(12):1152-1163.
15. Dunning A.M., Dowsett M., Healey C.S., Tee L., Luben R.N., Folkerd E., Novik K.L., Kelemen L., Ogata S., Pharoah P.D., Easton D.F., Day N.E., Ponder B.A. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J. Natl. Cancer Inst. 2004, 96(12):936-945.
16. Dunning A.M., Healey C.S., Baynes C., Maia A.T., Scollen S., Vega A., Rodriguez R., Barbosa-Morais N.L., Ponder B.A., Low Y.L., Bingham S., Haiman C.A., Le Marchand L., Broeks A., Schmidt M.K., Hopper J., Southey M., Beckmann M.W., Fasching P.A., Peto J., et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Hum. Mol. Genet. 2009, 18(6):1131-1139.
17. Eicheler W., Tuohimaa P., Vilja P., Adermann K., Forssmann W.G., Aumuller G. Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J. Histochem. Cytochem. 1994, 42(5):667-675.
18. Ellis J.A., Panagiotopoulos S., Akdeniz A., Jerums G., Harrap S.B. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1. J. Hum. Genet. 2005, 50(10):534-537.
19. Eriksson A.L., Lorentzon M., Vandenput L., Labrie F., Lindersson M., Syvanen A.C., Orwoll E.S., Cummings S.R., Zmuda J.M., Ljunggren O., Karlsson M.K., Mellstrom D., Ohlsson C. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J. Clin. Endocrinol. Metab. 2009, 94(3):1033-1041.
20. Feigelson H.S., Shames L.S., Pike M.C., Coetzee G.A., Stanczyk F.Z., Henderson B.E. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res. 1998, 58(4):585-587.
21. Figtree G.A., Grieve S.M., Speller B., Geiger M.J., Robinson B.G., Channon K.M., Ragoussis J., Collins P., Watkins H. A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL. Atherosclerosis 2008, 199(2):354-361.
22. Gallagher C.J., Langefeld C.D., Gordon C.J., Campbell J.K., Mychaleckyj J.C., Bryer-Ash M., Rich S.S., Bowden D.W., Sale M.M. Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the insulin resistance atherosclerosis family Study. Diabetes 2007, 56(8):2135-2141.
23. Garringer J., Niyonkuru C., McCullough E., Loucks T.L., Dixon C.E., Conley Y.P., Berga S., Wagner A.M.D. Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI. J. Neurotrauma 2013, March 29, (Epub ahead of print).
24. Gillberg C., Cederlund M., Lamberg K., Zeijlon L. Brief report: "the autism epidemic", The registered prevalence of autism in a Swedish urban area. J. Autism Dev. Disord. 2006, 36(3):429-435.
25. Goodarzi M.O., Shah N.A., Antoine H.J., Pall M., Guo X., Azziz R. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J. Clin. Endocrinol. Metab. 2006, 91(10):4085-4091.
26. Graupp M., Wehr E., Schweighofer N., Pieber T.R., Obermayer-Pietsch B. Association of genetic variants in the two isoforms of 5alpha-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 157(2):175-179.
27. Hannelius U., Gherman L., Makela V.V., Lindstedt A., Zucchelli M., Lagerberg C., Tybring G., Kere J., Lindgren C.M. Large-scale zygosity testing using single nucleotide polymorphisms. Twin Res. Hum. Genet. 2007, 10(4):604-625.
28. Hansson S.L., Svanstrom Rojvall A., Rastam M., Gillberg C., Anckarsater H. Psychiatric telephone interview with parents for screening of childhood autism-tics, attention-deficit hyperactivity disorder and other comorbidities (A-TAC): preliminary reliability and validity. Br. J. Psychiatry 2005, 187:262-267.
29. Happe F., Ronald A. The 'fractionable autism triad': a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol. Rev. 2008, 18(4):287-304.
30. Henningsson S., Jonsson L., Ljunggren E., Westberg L., Gillberg C., Rastam M., Anckarsater H., Nygren G., Landen M., Thuresson K., Betancur C., Leboyer M., Eriksson E., Melke J. Possible association between the androgen receptor gene and autism spectrum disorder. Psychoneuroendocrinology 2009, 34(5):752-761.
31. Hill R.A., McInnes K.J., Gong E.C., Jones M.E., Simpson E.R., Boon W.C. Estrogen deficient male mice develop compulsive behavior. Biol. Psychiatry 2007, 61(3):359-366.
32. Hu V.W., Nguyen A., Kim K.S., Steinberg M.E., Sarachana T., Scully M.A., Soldin S.J., Luu T., Lee N.H. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS ONE 2009, 4(6):e5775.
33. Huo L., Straub R.E., Roca C., Schmidt P.J., Shi K., Vakkalanka R., Weinberger D.R., Rubinow D.R. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol. Psychiatry 2007, 62(8):925-933.
34. Iivonen S., Corder E., Lehtovirta M., Helisalmi S., Mannermaa A., Vepsalainen S., Hanninen T., Soininen H., Hiltunen M. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 2004, 62(7):1170-1176.
35. Imwalle D.B., Scordalakes E.M., Rissman E.F. Estrogen receptor alpha influences socially motivated behaviors. Horm. Behav. 2002, 42(4):484-491.
36. Ingudomnukul E., Baron-Cohen S., Wheelwright S., Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm. Behav. 2007, 51(5):597-604.
37. Keene K.L., Mychaleckyj J.C., Smith S.G., Leak T.S., Perlegas P.S., Langefeld C.D., Herrington D.M., Freedman B.I., Rich S.S., Bowden D.W., Sale M.M. Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population. Hum. Genet. 2008, 123(4):333-341.
38. Klei L., Sanders S.J., Murtha M.T., Hus V., Lowe J.K., Willsey A.J., Moreno-De-Luca D., Yu T.W., Fombonne E., Geschwind D., Grice D.E., Ledbetter D.H., Lord C., Mane S.M., Lese Martin C., Martin D.M., Morrow E.M., Walsh C.A., Melhem N.M., Chaste P., et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol. Autism 2012, 3(1):9.
39. Koudu Y., Onouchi T., Hosoi T., Horiuchi T. Association of CYP19 gene polymorphism with vertebral fractures in Japanese postmenopausal women. Biochem. Genet. 2012, 50(5-6):389-396.
40. Larson T., Anckarsater H., Gillberg C., Stahlberg O., Carlstrom E., Kadesjo B., Rastam M., Lichtenstein P. The autism-tics, AD/HD and other comorbidities inventory (A-TAC): further validation of a telephone interview for epidemiological research. BMC Psychiatry 2010, 10:1.
41. Lenz B., Schopp E., Muller C.P., Bleich S., Hillemacher T., Kornhuber J. Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts. Psychopharmacology (Berl.) 2012, 224(3):421-429.
42. Levesque E., Huang S.P., Audet-Walsh E., Lacombe L., Bao B.Y., Fradet Y., Laverdiere I., Rouleau M., Huang C.Y., Yu C.C., Caron P., Guillemette C. Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clin. Cancer Res. 2013, 19(3):699-709.
43. Li J., Coates R.J., Gwinn M., Khoury M.J. Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review. Am. J. Epidemiol. 2010, 171(1):1-13.
44. Lichtenstein P., Carlstrom E., Rastam M., Gillberg C., Anckarsater H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am. J. Psychiatry 2010, 167(11):1357-1363.
45. Lombardo M.V., Ashwin E., Auyeung B., Chakrabarti B., Taylor K., Hackett G., Bullmore E.T., Baron-Cohen S. Fetal testosterone influences sexually dimorphic gray matter in the human brain. J. Neurosci. 2012, 32(2):674-680.
46. Lundstrom S., Chang Z., Rastam M., Gillberg C., Larsson H., Anckarsater H., Lichtenstein P. Autism spectrum disorders and autistic like traits: similar etiology in the extreme end and the normal variation. Arch. Gen. Psychiatry 2012, 69(1):46-52.
47. Lurie G., Wilkens L.R., Thompson P.J., McDuffie K.E., Carney M.E., Terada K.Y., Goodman M.T. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control 2009, 20(1):47-55.
48. Makridakis N., Ross R.K., Pike M.C., Chang L., Stanczyk F.Z., Kolonel L.N., Shi C.Y., Yu M.C., Henderson B.E., Reichardt J.K. A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res. 1997, 57(6):1020-1022.
49. Makridakis N.M., di Salle E., Reichardt J.K. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 2000, 10(5):407-413.
50. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int. J. Cancer 2010, 126(12):2935-2946.
51. Martorell L., Costas J., Valero J., Gutierrez-Zotes A., Phillips C., Torres M., Brunet A., Garrido G., Carracedo A., Guillamat R., Valles V., Guitart M., Labad A., Vilella E. Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophr. Res. 2008, 100(1-3):308-315.
52. Matsumoto Y., Suzuki A., Shibuya N., Sadahiro R., Kamata M., Goto K., Otani K. Effect of the cytochrome P450 19 (aromatase) gene polymorphism on personality traits in healthy subjects. Behav. Brain Res. 2009, 205(1):234-237.
53. McCarthy M.M. How it's made: organisational effects of hormones on the developing brain. J. Neuroendocrinol. 2010, 22(7):736-742.
54. Milivojevic V., Kranzler H.R., Gelernter J., Burian L., Covault J. Variation in genes encoding the neuroactive steroid synthetic enzymes 5alpha-reductase type 1 and 3alpha-reductase type 2 is associated with alcohol dependence. Alcohol. Clin. Exp. Res. 2011, 35(5):946-952.
55. Miodovnik A., Diplas A.I., Chen J., Zhu C., Engel S.M., Wolff M.S. Polymorphisms in the maternal sex steroid pathway are associated with behavior problems in male offspring. Psychiatr. Genet. 2012, 22(3):115-122.
56. Nordahl C.W., Scholz R., Yang X., Buonocore M.H., Simon T., Rogers S., Amaral D.G. Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study. Arch. Gen. Psychiatry 2012, 69(1):53-61.
57. Ohlsson C., Wallaschofski H., Lunetta K.L., Stolk L., Perry J.R., Koster A., Petersen A.K., Eriksson J., Lehtimaki T., Huhtaniemi I.T., Hammond G.L., Maggio M., Coviello A.D., Ferrucci L., Heier M., Hofman A., Holliday K.L., Jansson J.O., Kahonen M., Karasik D., et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet. 2011, 7(10):e1002313.
58. Paba S., Frau R., Godar S.C., Devoto P., Marrosu F., Bortolato M. Steroid 5alpha-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders. Curr. Pharm. Des. 2011, 17(2):151-167.
59. Perry J.R., Weedon M.N., Langenberg C., Jackson A.U., Lyssenko V., Sparso T., Thorleifsson G., Grallert H., Ferrucci L., Maggio M., Paolisso G., Walker M., Palmer C.N., Payne F., Young E., Herder C., Narisu N., Morken M.A., Bonnycastle L.L., Owen K.R., et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum. Mol. Genet. 2010, 19(3):535-544.
60. Pfaff D.W., Rapin I., Goldman S. Male predominance in autism: neuroendocrine influences on arousal and social anxiety. Autism Res. 2011, 4(3):163-176.
61. Pierman S., Sica M., Allieri F., Viglietti-Panzica C., Panzica G.C., Bakker J. Activational effects of estradiol and dihydrotestosterone on social recognition and the arginine-vasopressin immunoreactive system in male mice lacking a functional aromatase gene. Horm. Behav. 2008, 54(1):98-106.
62. Ralph D.A., Zhao L.P., Aston C.E., Manjeshwar S., Pugh T.W., DeFreese D.C., Gramling B.A., Shimasaki C.D., Jupe E.R. Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk. Cancer 2007, 109(10):1940-1948.
63. Riancho J.A., Sanudo C., Valero C., Pipaon C., Olmos J.M., Mijares V., Fernandez-Luna J.L., Zarrabeitia M.T. Association of the aromatase gene alleles with BMD: epidemiological and functional evidence. J. Bone Miner. Res. 2009, 24(10):1709-1718.
64. Ronald A., Butcher L.M., Docherty S., Davis O.S., Schalkwyk L.C., Craig I.W., Plomin R. A genome-wide association study of social and non-social autistic-like traits in the general population using pooled DNA, 500K SNP microarrays and both community and diagnosed autism replication samples. Behav. Genet. 2010, 40(1):31-45.
65. Ronald A., Larsson H., Anckarsater H., Lichtenstein P. A twin study of autism symptoms in Sweden. Mol. Psychiatry 2011, 16(10):1039-1047.
66. Rosenberg R.E., Law J.K., Yenokyan G., McGready J., Kaufmann W.E., Law P.A. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch. Pediatr. Adolesc. Med. 2009, 163(10):907-914.
67. Ruta L., Ingudomnukul E., Taylor K., Chakrabarti B., Baron-Cohen S. Increased serum androstenedione in adults with autism spectrum conditions. Psychoneuroendocrinology 2011, 36(8):1154-1163.
68. Ryan J., Canonico M., Carcaillon L., Carriere I., Scali J., Dartigues J.F., Dufouil C., Ritchie K., Scarabin P.Y., Ancelin M.L. Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study. PLoS ONE 2012, 7(3):e34112.
69. Sanchez-Andrade G., Kendrick K.M. Roles of alpha- and beta-estrogen receptors in mouse social recognition memory: effects of gender and the estrous cycle. Horm. Behav. 2011, 59(1):114-122.
70. Sarachana T., Xu M., Wu R.C., Hu V.W. Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PLoS ONE 2011, 6(2):e17116.
71. Schmidtova E., Kelemenova S., Celec P., Ficek A., Ostatnikova D. Polymorphisms in genes involved in testosterone metabolism in Slovak autistic boys. Endocrinologist 2010, 20(5):245-249.
72. Scorilas A., Bharaj B., Giai M., Diamandis E.P. Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer. Br. J. Cancer 2001, 84(6):760-767.
73. Setiawan V.W., Doherty J.A., Shu X.O., Akbari M.R., Chen C., De Vivo I., Demichele A., Garcia-Closas M., Goodman M.T., Haiman C.A., Hankinson S.E., Henderson B.E., Horn-Ross P.L., Lacey J.V., Le Marchand L., Levine D.A., Liang X., Lissowska J., Lurie G., McGrath M., et al. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol. Biomarkers Prev. 2009, 18(1):242-247.
74. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., Gudbjartsson D.F., Walters G.B., Ingvarsson T., Jonsdottir T., Saemundsdottir J., Center J.R., Nguyen T.V., Bagger Y., Gulcher J.R., Eisman J.A., Christiansen C., Sigurdsson G., Kong A., Thorsteinsdottir U., Stefansson K. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 2008, 358(22):2355-2365.
75. Tchatchou S., Jung A., Hemminki K., Sutter C., Wappenschmidt B., Bugert P., Weber B.H., Niederacher D., Arnold N., Varon-Mateeva R., Ditsch N., Meindl A., Schmutzler R.K., Bartram C.R., Burwinkel B. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009, 30(1):59-64.
76. Tordjman S., Ferrari P., Sulmont V., Duyme M., Roubertoux P. Androgenic activity in autism. Am. J. Psychiatry 1997, 154(11):1626-1627.
77. Treutlein J., Cichon S., Ridinger M., Wodarz N., Soyka M., Zill P., Maier W., Moessner R., Gaebel W., Dahmen N., Fehr C., Scherbaum N., Steffens M., Ludwig K.U., Frank J., Wichmann H.E., Schreiber S., Dragano N., Sommer W.H., Leonardi-Essmann F., et al. Genome-wide association study of alcohol dependence. Arch. Gen. Psychiatry 2009, 66(7):773-784.
78. Vaillancourt K.L., Dinsdale N.L., Hurd P.L. Estrogen receptor 1 promoter polymorphism and digit ratio in men. Am. J. Hum. Biol. 2012, 24(5):682-689.
79. Versini A., Ramoz N., Le Strat Y., Scherag S., Ehrlich S., Boni C., Hinney A., Hebebrand J., Romo L., Guelfi J.D., Gorwood P. Estrogen receptor 1 gene (ESR1) is associated with restrictive anorexia nervosa. Neuropsychopharmacology 2010, 35(8):1818-1825.
80. Von Horn A., Backman L., Davidsson T., Hansen S. Empathizing, systemizing and finger length ratio in a Swedish sample. Scand. J. Psychol. 2010, 51(1):31-37.
81. Wang C., Tao W., Chen Q., Hu H., Wen X.Y., Han R. SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis. Prostate 2010, 70(2):170-178.
82. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., Salyakina D., Imielinski M., Bradfield J.P., Sleiman P.M., Kim C.E., Hou C., Frackelton E., Chiavacci R., Takahashi N., Sakurai T., Rappaport E., Lajonchere C.M., Munson J., Estes A., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459(7246):528-533.
83. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., Straub R.E., Weinberger D.R., Kleinman J.E. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum. Mol. Genet. 2008, 17(15):2293-2309.
84. Weiss L.A., Arking D.E., Daly M.J., Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009, 461(7265):802-808.
85. Westberg L., Eriksson E. Sex steroid-related candidate genes in psychiatric disorders. J. Psychiatry Neurosci. 2008, 33(4):319-330.
86. Westberg L., Hakansson A., Melke J., Shahabi H.N., Nilsson S., Buervenich S., Carmine A., Ahlberg J., Grundell M.B., Schulhof B., Klingborg K., Holmberg B., Sydow O., Olson L., Johnels E.B., Eriksson E., Nissbrandt H. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease. Psychoneuroendocrinology 2004, 29(8):993-998.
87. Yu K.D., Rao N.Y., Chen A.X., Fan L., Yang C., Shao Z.M. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk. Breast Cancer Res. Treat. 2011, 126(1):37-45.
88. Zhang L., Gu L., Qian B., Hao X., Zhang W., Wei Q., Chen K. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res. Treat. 2009, 114(2):327-338.
89. Zhuo F.L., Xu W., Wang L., Wu Y., Xu Z.L., Zhao J.Y. Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis. Clin. Exp. Dermatol. 2012, 37(2):104-111.